|  | PC/HPF, n/N (%) | EC/HPF, n/N (%) | RBCs/HPF, n/N (%) | CAPa/HPF, n/N (%) | ||||
---|---|---|---|---|---|---|---|---|---|
Age/yr | Prevalence n/N (%) |  < 5 |  > 5 |  < 15 |  > 15 |  < 5 |  > 5 | yes | no |
5–15 | 9/845 (1.1) | 9/9 (100) | - | 7/9 (77.8) | 2/9 (22.2) | 9/9 (100) | - | 5/9 (55.6) | 4/9 (44.4) |
16–20 | 158/845 (18.7) | 130/158 (82.3) | 28/158 (17.7) | 107/158 (67.7) | 51/158 (32.3) | 147/158 (93.0) | 11/158 (7.0) | 95/158 (60.1) | 63/158 (39.9) |
21–30 | 482/845 (57.0) | 381/482 (79.0) | 101/482 (21.0) | 298/482 (61.8) | 184/482 (38.2) | 446/482 (92.5) | 36/482 (7.5) | 304/482 (63.1) | 178/482 (36.9) |
31–40 | 152/845 (18.0) | 121/152 (79.6) | 31/152 (20.4) | 99/152 (65.1) | 53/152 (34.9) | 145/152 (95.4) | 7/152 (4.6) | 106/152 (69.7) | 46/152 (30.3) |
41–50 | 31/845 (3.7) | 26/31 (83.9) | 5/31 (16.1) | 21/31 (67.7) | 10/31 (32.3) | 30/31 (96.8) | 1/31 (3.2) | 17/31 (54.8) | 14/31 (45.2) |
51–60 | 6/845 (0.7) | 1/6 (16.7) | 5/6 (83.3) | 5/6 (83.3) | 1/6 (16.7) | 6/6 (100) | - | 2/6 (33.3) | 4/6 (66.7) |
61–70 | 7/845 (0.8) | 4/7 (57.1) | 3/7 (42.9) | 3/7 (42.9) | 4/7 (57.1) | 7/7 (100) | - | 2/7 (28.6) | 5/7 (71.4) |